Reconnecting Practicing Hygienists with the Nation's Leading Educators and Researchers.

The Overlooked Connection Between Mental and Oral Health

Depression can create a cascade of oral health challenges that dental hygienists are uniquely positioned to recognize and address.

Depression is a prevalent mental health disorder with significant implications for oral health.1 Behavioral changes associated with depression, combined with medication-induced xerostomia, increase susceptibility to dental caries and periodontal diseases. Reduced salivary flow alters the oral microbiome, promotes plaque accumulation, and contributes to inflammatory processes that negatively affect periodontal outcomes. Furthermore, depression has been linked to systemic inflammatory pathways that may influence periodontal disease progression and treatment outcomes.2 Dental hygienists are uniquely positioned to identify at-risk patients, implement individualized preventive strategies, and participate in interdisciplinary care.

One of the most common oral manifestations associated with depression and its pharmacologic treatment is xerostomia.1 Xerostomia is the subjective sensation of oral dryness and is often associated with reduced salivary flow (hyposalivation). Antidepressant medications, particularly selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and tricyclic antidepressants (TCAs), are among the most frequently implicated causes of medication-induced xerostomia.3,4 Reduced salivary flow diminishes the protective functions of saliva, increasing susceptibility to dental caries, periodontal diseases, oral infections, and mucosal discomfort.1

The relationship between depression and oral health is multifactorial and bidirectional. Periodontal diseases contribute to systemic inflammation, which has been implicated in the development of depressive disorders.5,6 Elevated inflammatory biomarkers, including interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha), are commonly observed in both conditions, suggesting shared pathogenic pathways.5,7 These inflammatory mediators may influence central nervous system activity and neurotransmitter function, contributing to depressive symptomatology.8

Depression can significantly impair self-care behaviors and increase engagement in lifestyle practices that negatively impact oral health.3,9 Conversely, chronic oral disease may adversely affect quality of life, social interactions, and self-esteem, thereby exacerbating depressive symptoms.4,10

Depression and Oral Health Behaviors

Depression significantly affects an individual’s ability to perform daily self-care behaviors, including oral hygiene. Symptoms, such as fatigue, diminished motivation, cognitive impairment, and the inability to feel pleasure, can interfere with routine activities, leading to inadequate brushing and flossing practices.11 These behavioral changes often result in rapid accumulation of dental biofilm and increased gingival inflammation. In many cases, patients may also experience reduced energy for maintaining routine health habits.2

Patients with depression commonly exhibit increased plaque accumulation, demonstrate inconsistent oral hygiene routines, delay or forgo preventive dental appointments, and put off seeking treatment for oral health concerns.2,11 Collectively, these behaviors contribute to increased biofilm accumulation and gingival inflammation.

Research indicates that psychological stress and depression influence periodontal health not only through behavioral pathways but also through physiologic mechanisms, including alterations in immune response and inflammatory regulation.9 In addition, chronic stress may impair healing responses and reduce the effectiveness of periodontal therapy.12

Depression has also been associated with dysregulation of the hypothalamic-pituitary-adrenal axis, which may affect host immune response and increase susceptibility to infection and inflammation. This biologic component further compounds the effects of poor oral hygiene habits. Altered cortisol levels associated with chronic stress may suppress immune defenses while simultaneously promoting inflammatory activity within periodontal tissues.13,14

Lifestyle factors associated with depression may further increase oral health risks. Tobacco use, for example, is more prevalent among individuals with depression.3 The growing use of electronic cigarettes and vaping products also warrants consideration, as emerging evidence suggests these products may contribute to oral inflammation, alterations in the oral microbiome, and increased risk of periodontal disease.15 Alcohol misuse, which frequently coexists with depressive disorders, may exacerbate xerostomia, impair healing, and contribute to poor oral hygiene practices and nutritional deficiencies.16 Additionally, recreational drug use has been associated with xerostomia.17

Nutritional habits may also change, with increased consumption of refined carbohydrates and decreased intake of nutrient-rich foods, contributing to caries risk and impaired periodontal healing.18 Furthermore, dehydration or inadequate fluid intake, common in some individuals experiencing depressive symptoms, may exacerbate oral dryness and further contribute to an unfavorable oral environment.16

Medication-Induced Xerostomia

Xerostomia is one of the most significant oral complications associated with depression. Antidepressants are widely prescribed and frequently associated with reduced salivary flow.1,19 In many patients, this side effect develops gradually and may worsen over time.19

These medications impair salivary gland function through anticholinergic and sympathomimetic mechanisms, resulting in decreased salivary secretion. The prevalence and severity of xerostomia often increase with polypharmacy, which is common in patients with multiple chronic health conditions.19 Other commonly prescribed drugs, including antihypertensives, antihistamines, and anxiolytics, may further exacerbate salivary dysfunction, compounding the overall risk for oral health complications.19,20

Saliva plays a vital role in maintaining oral homeostasis by buffering acids produced by bacterial metabolism, providing antimicrobial properties, facilitating remineralization of enamel, and assisting in mechanical cleansing of oral tissues.21 When salivary flow is reduced, these protective functions are compromised. Patients become more susceptible to caries, periodontal diseases, candidiasis, and mucosal irritation.22 In addition, xerostomia can significantly impact quality of life, affecting speech, swallowing, taste perception, and overall comfort.23 Patients may also have trouble wearing removable prostheses due to lack of lubrication. Table 1 (page 19) provides symptoms and observable clinical signs.21,23

Table 1. Common Patient-Reported Symptoms and Clinical Signs of Xerostomia21,23
Patient-Reported Symptoms Clinical Signs Clinical Implications
Persistent oral dryness Dry mucosal tissues Increased risk for caries, periodontal diseases, and oral infections
Difficulty eating dry foods Thick or ropey saliva Reduced lubrication and impaired oral function
Increased thirst Fissured tongue Greater susceptibility to mucosal irritation and discomfort
Difficulty speaking or swallowing Erythematous mucosa (in severe cases) May indicate significant salivary gland dysfunction
Altered taste sensation Mucosal atrophy (in severe cases) Increased susceptibility to trauma, delayed healing, and infection

Xerostomia and Periodontal Outcomes

Salivary flow plays a critical role in maintaining oral homeostasis by regulating the oral microbiome and facilitating mechanical clearance of bacteria and food debris. Reduced salivary secretion disrupts these protective mechanisms, creating an environment that favors the growth of pathogenic bacterial species and promotes microbial dysbiosis.1,24 Periodontal pathogens have been detected in greater abundance in saliva from individuals with periodontal diseases.25,26

Decreased salivary flow also impairs the natural cleansing of oral tissues. Changes in salivary composition, oxygen availability, and pH may further support the growth of anaerobic bacteria associated with periodontal destruction.7,25 As biofilm matures, it becomes increasingly pathogenic and more capable of eliciting a host inflammatory response.1,25

The inflammatory response associated with periodontal diseases extends beyond the oral cavity. Elevated inflammatory mediators produced within periodontal tissues may enter systemic circulation.5 Shared inflammatory pathways involving cytokines, such as IL-6 and TNF-alpha, have also been implicated in depression.5,6,10

Clinical Presentation and Assessment

Patients with depression and xerostomia often present with generalized gingival inflammation, increased bleeding on probing, elevated plaque scores, greater clinical attachment loss, increased incidence of root caries, oral candidiasis, mucosal sensitivity, and increased plaque retention in areas that are typically self-cleansing. This population also has difficulty maintaining adequate oral hygiene.1,2,11,27

Comprehensive assessment is essential for identifying patients at risk for depression-related oral health complications. Dental hygienists should evaluate medical, behavioral, salivary, and periodontal risk factors to facilitate early intervention and individualized care planning.19,22

Chairside Assessment Guide for Patients With Depression and Xerostomia20,23
Assessment Area What to Evaluate Chairside Considerations
Medical history and risk
  • Antidepressant medications
  • Xerogenic drug combinations
  • Systemic health conditions
  • Duration of medication use
  • Recent medication changes
Review prescription history carefully. Consider cumulative xerogenic effects of multiple medications and assess for conditions that may increase oral disease risk.
Patient communication
  • Overall health status
  • Medication adherence
  • Daily self-care routines
  • Barriers to oral hygiene
Use open-ended questions and motivational interviewing techniques to identify challenges related to depression, fatigue, reduced motivation, or oral discomfort.
Xerostomia screening
  • Dry mouth symptoms
  • Difficulty swallowing or eating dry foods
  • Increased thirst
  • Oral discomfort
Document patient-reported symptoms and monitor changes over time to assess response to interventions.
Clinical salivary assessment
  • Saliva quantity
  • Saliva consistency
  • Presence of saliva pooling
  • Oral tissue moisture
Observe for thick or ropey saliva, limited salivary pooling, dry mucosal surfaces, or other signs of salivary gland dysfunction.
Periodontal assessment
  • Probing depths
  • Clinical attachment levels
  • Bleeding on probing
  • Plaque and calculus accumulation
Identify areas of active inflammation and evidence of disease progression that may be associated with inadequate oral hygiene or xerostomia.
Disease monitoring
  • Changes in periodontal status
  • Caries activity
  • Xerostomia symptoms
  • Oral hygiene effectiveness
Compare findings at each visit to identify patterns, evaluate treatment effectiveness, and modify care plans as needed.

A comprehensive medical history should include a review of antidepressant medications, identification of xerogenic drug combinations, and evaluation of systemic health conditions.19 In addition, clinicians should assess the duration of medication use and any recent changes in prescriptions, as these factors may influence the severity of xerostomia and oral disease risk. Asking open-ended questions about overall health, medication adherence, and daily routines can help identify patients who may be struggling with depression. This approach aligns with motivational interviewing techniques, which have been shown to enhance patient engagement, self-efficacy, and adherence to recommended oral health behaviors.22

Screening for xerostomia should include documentation of patient-reported symptoms, clinical observation of oral tissues, and evaluation of salivary flow and consistency. Combining subjective and objective assessments improves diagnostic accuracy.19 Clinicians may consider using simple chairside assessments, such as observing saliva pooling or testing salivary consistency, to better evaluate severity.

A periodontal evaluation should include documentation of probing depths and attachment levels, bleeding on probing, plaque and calculus accumulation, and disease progression over time. Documentation of changes allows for more effective management and evaluation of treatment outcomes. Identifying patterns can help tailor treatment plans and identify contributing factors such as inadequate oral hygiene or xerostomia.

Implications for Dental Hygiene Care Plans

Patients with depression and xerostomia require individualized preventive approaches, including shortened recare intervals (3 to 4 months), frequent periodontal maintenance, and the application of topical fluoride. These interventions help reduce disease progression and improve oral health outcomes.

Xerostomia management may include saliva substitutes, xylitol-containing products to stimulate salivary flow, and increased hydration. Effective management improves patient comfort and reduces oral disease risk.19 Patient education regarding the causes of xerostomia and its oral health implications is critical to improving compliance. Clinicians may also recommend prescription fluoride toothpaste, power toothbrushes, and interdental cleaning devices suited to patient ability. Simplifying oral hygiene routines can improve adherence and effectiveness.

Motivational interviewing is a patient-centered communication strategy that can improve adherence to oral hygiene practices.Tailoring communication to the patient’s readiness for change and addressing barriers, such as low motivation or mental fatigue, can significantly enhance the effectiveness of preventive care strategies.

Interprofessional Collaboration

Managing patients with depression requires collaboration among dental and medical professionals. Dental hygienists should communicate findings with primary care providers, educate patients about medication effects, and encourage continued mental healthcare. Oral health professionals play a valuable role by identifying oral manifestations that may be related to systemic conditions or medication side effects and relaying this information to the broader healthcare team.27,28 Collaboration may also involve mental health professionals.

Effective communication among providers helps ensure that treatment plans are coordinated and that potential complications are addressed holistically.27,28 Building strong referral networks and fostering open communication can enhance continuity of care and improve patient compliance.

Future Directions

Understanding the underlying biologic mechanisms that link periodontal diseases with systemic and psychological conditions is imperative. Advances in salivary diagnostics and microbiome research may allow for earlier detection and more personalized treatment strategies.7 Novel technologies, such as chairside salivary testing and genomic profiling of oral bacteria, may improve risk assessment and enable clinicians to tailor preventive and therapeutic interventions to individual patients.

Integrating behavioral health screening into dental settings may further improve patient outcomes and enhance preventive care.26 Future models of care may incorporate routine screening for depression and other mental health conditions within dental visits, allowing for earlier identification and referral. Additionally, expanding education and training for dental hygienists in areas, such as behavioral health, communication strategies, and interdisciplinary collaboration, will be critical to supporting this evolving role in comprehensive patient care.

Depression, xerostomia, and periodontal diseases are interconnected through behavioral, microbial, and inflammatory pathways that can significantly affect oral health outcomes. Dental hygienists play a critical role in identifying at-risk patients and implementing evidence-based interventions through comprehensive assessment, individualized care planning, and interdisciplinary collaboration. By addressing both the oral and systemic effects of depression, dental hygienists can help reduce disease progression, improve treatment outcomes, and enhance patients’ overall quality of life.

References

  1. Alcázar-Hernández JM, Pecci-Lloret MR, Guerrero-Gironés J. Oral manifestations in patients in treatment with antidepressants: a systematic review. J Clin Med. 2024;13:6945.
  2. Bafageeh F, Loux T. Depression symptoms linked to multiple oral health outcomes in US adults. JDR Clin Trans Res. 2025;10:64-73.
  3. Kim MY, Pang EK. Relationship between periodontitis and systemic health conditions: a narrative review. Ewha Med J. 2025;48:e27.
  4. Dumitrescu AL. Depression and inflammatory periodontal disease considerations-an interdisciplinary approach. Front Psychol. 2016;7:347.
  5. Hashioka S, Inoue K, Hayashida M, Wake R, Oh-Nishi A, Miyaoka T. The implications of systemic inflammation and periodontitis for major depression. Front Neurosci. 2018;12:483.
  6. Hajishengallis G, Chavakis T. Local and systemic mechanisms linking periodontal disease and inflammatory conditions. Nat Rev Immunol. 2021;21:426-440.
  7. Radu CM, Radu CC, Zaha DC. Salivary and microbiome biomarkers in periodontitis: advances in diagnosis and therapy. Medicina (Kaunas). 2025;61:1818.
  8. Kouba BR, Borba LA, de Souza PB, Gil-Mohapel J, Rodrigues ALS. Role of inflammatory mechanisms in major depressive disorder: from etiology to potential pharmacological targets. Cells. 2024;13:423.
  9. Castro MML, Ferreira RO, Fagundes NCF, Almeida APCPSC, Maia LC, Lima RR. Association between psychological stress and periodontitis: a systematic review. Eur J Dent. 2020;14:171-179.
  10. Arnett MC, Rogers KM, Evans MD, Reibel Y. Effectiveness of brief motivational interviewing on perceived importance, interest and self-efficacy of oral health behaviors: a randomized clinical trial. PEC Innov. 2022;1:100092.
  11. Heaton LJ, Santoro M, Tiwari T, et al. Mental health, socioeconomic position, and oral health: a path analysis. Prev Chronic Dis. 2024;21:240097.
  12. Mauland EK, Neupane SP. The influence of psychological stress and stress-related disorders in the treatment outcome of periodontitis: a systematic review and meta-analysis. J Clin Periodontol. 2025;52:1760-1778.
  13. Jiao W, Lin J, Deng Y, et al. The immunological perspective of major depressive disorder: unveiling the interactions between central and peripheral immune mechanisms. J Neuroinflammation. 2025;22:10.
  14. Macrì M, D’Albis G, D’Albis V, et al. Periodontal health and its relationship with psychological stress: a cross-sectional study. J Clin Med. 2024;13:2942.
  15. Charde P, Ali K, Hamdan N. Effects of e-cigarette smoking on periodontal health: a scoping review. PLoS Glob Public Health. 2024;4:e0002311.
  16. Gandhi UH, Benjamin A, Gajjar S, et al. Alcohol and periodontal disease: a narrative review. Cureus. 2024;16:e62270.
  17. Clonan E, Shah P, Cloidt M, Laniado N. Frequent recreational cannabis use and its association with caries and severe tooth loss: findings from the National Health and Nutrition Examination Survey, 2015-2018. J Am Dent Assoc. 2025;156:9-16.
  18. Berg Y, Gabay E, Božić D, et al. The impact of nutritional components on periodontal health: a literature review. Nutrients. 2024;16:3901.
  19. Teoh CW, Thng M, Lau S, et al. Dry mouth effects from drugs used for depression, anxiety, schizophrenia and bipolar disorder in adults: a systematic review. BJPsych Open. 2023;9:e53.
  20. Abdou LP, Grégoire KK, Mamadou D, et al. Antihypertensive medications inducing salivary gland dysfunction and xerostomia: a narrative review. Adv Appl Physiol. 2023;8:40-46.
  21. Okuyama K, Yanamoto S. Saliva in balancing oral and systemic health, oral cancer, and beyond: a narrative review. Cancers (Basel). 2024;16:4276.
  22. Pedersen AML, Sørensen CE, Proctor GB, Carpenter GH, Ekström J. Saliva and oral health and disease. J Dent Res. 2018;97:601-609.
  23. Müller F, Chebib N, Maniewicz S, Genton L. The impact of xerostomia on food choices: a review with clinical recommendations. J Clin Med. 2023;12:4592.
  24. Song EAC, Chung SH, Kim JH. Molecular mechanisms of saliva secretion and hyposecretion. Eur J Oral Sci. 2024;132:e12969.
  25. Belstrøm D, Danielsen AK, Enevold C, Massarenti L, Nielsen CH, Holmstrup P. Porphyromonas gingivalis in saliva associates with chronic and aggressive periodontitis. J Oral Microbiol. 2019;11:1653123.
  26. Lundmark A, Hu YOO, Huss M, Johannsen G, Andersson AF, Yucel-Lindberg T. Identification of salivary microbiota and its association with host inflammatory mediators in periodontitis. Front Cell Infect Microbiol. 2019;9:216.
  27. Taccardi D, Chiesa A, Maiorani C, et al. Periodontitis and depressive disorders: the effects of antidepressant drugs on the periodontium. J Clin Med. 2024;13:4524.
  28. Dsouza-Norwood R, Burgess-Flowers J, Sanders K. Effective approaches to addressing xerostomia. Dimensions of Dental Hygiene. 2022;20(11)42-45.

From Dimensions of Dental Hygiene. November/December 2026; 24(6):18-21

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

BLACK FRIDAY / CYBER MONDAY
CE PROMOTION

Coupon has expired Stay top of your profession with our evidence-based peer-reviewed continuing education courses written by world-class educators and researchers!
Get Black Friday CE Savings!